Driven by the addition of sales from its acquisition of Cynosure, women's imaging firm Hologic reported a 10% increase in revenues for the company's fourth quarter, although net income slipped.
For the period, Hologic posted sales of $802.9 million, compared with sales of $726.8 million in the fourth quarter of fiscal 2016. Without the addition of revenues from Cynosure, the company's sales still would have grown 4.4% at constant currency rates. The company's net income for the quarter came in at $82.7 million, compared with $92.2 million in the corresponding quarter the year before.
For the year, Hologic reported revenues of $3.059 billion, up 8% from revenues of $2.833 billion in fiscal 2016. The company's net income for the year was $755.5 million, compared with $330.8 million in 2016.
On a business line basis, sales in Hologic's Breast Health segment were $300.9 million, up 2.9% from $292.3 million the year before. The company said that revenue in the U.S. fell 1.2% as changes in product mix were offset by increases in service and new product revenue. International revenue grew 20.6% at constant currency rates.
